BlackRock’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-667,399
Closed -$551K 5457
2025
Q1
$551K Sell
667,399
-106,877
-14% -$88.2K ﹤0.01% 4325
2024
Q4
$736K Sell
774,276
-28,032
-3% -$26.6K ﹤0.01% 4256
2024
Q3
$802K Sell
802,308
-71,794
-8% -$71.8K ﹤0.01% 4175
2024
Q2
$1.08M Sell
874,102
-35,348
-4% -$43.8K ﹤0.01% 4106
2024
Q1
$1.18M Sell
909,450
-159,054
-15% -$207K ﹤0.01% 4098
2023
Q4
$1.34M Sell
1,068,504
-312,848
-23% -$391K ﹤0.01% 4096
2023
Q3
$1.8M Sell
1,381,352
-15,993
-1% -$20.8K ﹤0.01% 3972
2023
Q2
$2.4M Sell
1,397,345
-1,746,768
-56% -$3M ﹤0.01% 3895
2023
Q1
$4.59M Sell
3,144,113
-62,772
-2% -$91.6K ﹤0.01% 3589
2022
Q4
$5.2M Sell
3,206,885
-259,535
-7% -$420K ﹤0.01% 3634
2022
Q3
$11.6M Sell
3,466,420
-40,185
-1% -$135K ﹤0.01% 3287
2022
Q2
$12.8M Buy
3,506,605
+104,875
+3% +$382K ﹤0.01% 3306
2022
Q1
$24.6M Buy
3,401,730
+32,054
+1% +$232K ﹤0.01% 2974
2021
Q4
$45.8M Buy
3,369,676
+437,155
+15% +$5.94M ﹤0.01% 2676
2021
Q3
$61.5M Buy
2,932,521
+110,276
+4% +$2.31M ﹤0.01% 2494
2021
Q2
$67.6M Buy
2,822,245
+1,186,681
+73% +$28.4M ﹤0.01% 2466
2021
Q1
$47.9M Buy
1,635,564
+108,876
+7% +$3.19M ﹤0.01% 2605
2020
Q4
$45.6M Buy
+1,526,688
New +$45.6M ﹤0.01% 2483